News

Hypertension being missed in rheumatoid arthritis

13-Sep-07

GPs have been urged to screen patients with rheumatoid arthritis (RA) for hypertension, after UK research revealed it was not picked up in four out of 10 RA patients.
The study findings add weight to previous calls for the addition of RA to the quality framework.

It is known that RA is associated with an increased risk of cardiovascular events such as MI, stroke and heart failure.

But for this latest study, the researchers investigated the prevalence of hypertension in 400 patients with RA.

Measurements of BP were taken and patient records were examined for use of any hypertensive medications.

More than 280 patients were found to have hypertension. Of these, only 61 per cent were found to be taking any medication for it. The remainder had undiagnosed, untreated hypertension. Of the RA patients receiving hypertension treatment, only 22 per cent had it under control.

Lead researcher Professor George Kitas, a consultant rheumatologist in Birmingham, said: ‘RA behaviour is similar to diabetes in terms of CVD risk. GPs have been conditioned to control CVD in diabetic patients and should look to adopt a similar approach in RA patients.’

GPs should be more aware of the risks of hypertension in RA patients, said Professor Kitas.

‘The link is not documented as well as the increased risk of cardiovascular events,’ he said.

‘Including RA in the quality framework would help GPs to monitor RA patients’ BP and treat it as necessary.’

GPs should be careful when prescribing for RA patients with hypertension because drugs such as NSAIDs and oral steroids can increase BP, added Professor Kitas.

Dr David Armstrong, consultant rheumatologist from University Hospital in North Durham, said: ‘I have been an advocate of aggressive screening and treatment of risk factors like hypertension in RA patients in primary care. RA should be treated with the same priority as diabetes.’

Brighton GP Dr Sue Lips­combe also backed screening. She said many RA patients had inflamed arteries, causing vessels to swell and narrowing of the lumen.

‘This will lead to increased peripheral resistance and higher numbers with hypertension.’

Comment below and tell us what you think




Comments

1 comment

Sohrab MANEKSHA

12/09/2007

Could it be the case that exhibition of NSAIDs which is stillcurrent practice be responsible for the high incidence of reported hypertension either directly or via it's deleterious effect on the kidney which does not seem to be all that well accepted yet?

Only registered users may comment. Log in now or register for a free account.

Login to comment


forgotten your password?

Quick search - use * for an abbreviated search, eg nico*

 
 

Healthcare Republic Forums

 

Registrar

Golden rules for registrars

Medico-legal adviser Dr Jim Rodger offers some expert advice on how to excel as a GP registrar. Read more

Career paths - Working abroad in a rural practice

Dr Kingsley Poole describes the differences he experienced working at a remote practice in New Zeala... Read more

Professional development - Honing your presentation skills

Most people feel nervous facing an audience, but practice will make it easier, says Dr Kevin Brown. Read more

Show all articles

 

Latest Clinical Articles

Clinical Review - Malaria

Contributed by Dr Charlie Easmon specialist adviser in travel medicine and medical director at The N... Read more

Clinical Review - Renal colic

Contributed by Mr Ranan DasGupta, specialist registrar and Mr Jonathon Olsburgh, consultant urologic... Read more

Clinical Review - Stroke

By Dr Helen Hosker, GP and clinical commissioning lead for stroke, NHS Manchester, and Dr Pippa Tyrr... Read more

Show all clinical articles

MIMS Product News

New drug - Xamiol

Leo Pharma has launched Xamiol gel, a combination of calcipotriol + betamethasone, for the treatment... Read more

New drug - Xarelto

Bayer HealthCare has launched Xarelto (rivaroxaban) for the prevention of venous thromboembolism in ... Read more

New drug - Torisel

Wyeth has launched Torisel (temsirolimus), a first-line treatment for advanced renal cell carcinoma ... Read more

Jobs

 

Job of the Week